DOI: https://dx.doi.org/10.18565/therapy.2023.1.70-77
Roytberg G.E., Slastnikova I.D., Sharkhun O.O., Davydova A.S.
N.I. Pirogov Russian National Research Medical University of the Ministry of Healthcare of Russia, Moscow
1. Барбараш О.Л., Карпов Ю.А., Кашталап В.В. с соавт. Стабильная ишемическая болезнь сердца. Клинические рекомендации 2020. Российский кардиологический журнал. 2020; 25(11): 201–250. [Barbarash O.L., Karpov Yu.A., Kashtalap V.V. et al. 2020 Clinical practice guidelines for stable coronary artery disease. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2020; 25(11): 201–250 (In Russ.)]. https://dx.doi.org/10.15829/1560-4071-2020-4076. EDN: THCMQS. 2. Diamond G.A., Forrester J.S. Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. N Engl J Med. 1979; 300(24): 1350–58. https://dx.doi.org/10.1056/NEJM197906143002402. 3. Foldyna B., Udelson J.E., Karady J. et al. Pretest probability for patients with suspected obstructive coronary artery disease: Re-evaluating Diamond–Forrester for the contemporary era and clinical implications: Insights from the PROMISE trial. Eur Heart J Cardiovasc Imaging. 2019; 20(5): 574–81. https://dx.doi.org/10.1093/ehjci/jey182. 4. Juarez-Orozco L.E., Saraste A., Capodanno D. et al. Impact of a decreasing pre-test probability on the performance of diagnostic tests for coronary artery disease. Eur Heart J Cardiovasc Imaging. 2019; 20(11): 1198–207. https://dx.doi.org/10.1093/ehjci/jez054. 5. Knuuti J., Wijns W., Saraste A. et al; ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020; 41(3): 407–77. https://dx.doi.org/10.1093/eurheartj/ehz425. 6. Genders T.S., Steyerberg E.W., Alkadhi H. et al.; CAD Consortium. A clinical prediction rule for the diagnosis of coronary artery disease: validation, updating, and extension. Eur Heart J. 2011; 32(11): 1316–30. https://dx.doi.org/10.1093/eurheartj/ehr014. 7. Lee U.W., Ahn S., Shin Y.S. et al. Comparison of the CAD consortium and updated Diamond–Forrester scores for predicting obstructive coronary artery disease. Am J Emerg Med. 2021; 43: 200–4. https://dx.doi.org/10.1016/j.ajem.2020.02.056. 8. Winther S., Schmidt S.E., Mayrhofer T. et al. Incorporating coronary calcification into pre-test assessment of the likelihood of coronary artery disease. J Am Coll Cardiol. 2020; 76(21): 2421–32. https://dx.doi.org/10.1016/j.jacc.2020.09.585. 9. Fyyaz S., Rasoul H., Miles C. et al. ESC 2019 guidelines on chronic coronary syndromes: could calcium scoring improve detection of coronary artery disease in patients with low risk score. Findings from a retrospective cohort of patients in a district general hospital. JRSM Cardiovasc Dis. 2021; 10: 20480040211032789. https://dx.doi.org/10.1177/20480040211032789. 10. Nicoll R., Wiklund U., Zhao Y. et al. The coronary calcium score is a more accurate predictor of significant coronary stenosis than conventional risk factors in symptomatic patients: Euro-CCAD study. Int J Cardiol. 2016; 207: 13–19.https://dx.doi.org/10.1016/j.ijcard.2016.01.056. 11. Baskaran L., Neo Y.P., Lee J.K. et al. Evaluating the coronary artery disease consortium model and the coronary artery calcium score in predicting obstructive coronary artery disease in a symptomatic mixed Asian cohort. J Am Heart Assoc. 2022; 11(8): e022697. https://dx.doi.org/10.1161/JAHA.121.022697. 12. Kolossvary M., Mayrhofer T., Ferencik M.et al. Are risk factors necessary for pretest probability assessment of coronary artery disease? A patient similarity network analysis of the PROMISE trial. J Cardiovasc Comput Tomogr. 2022; 16(5): 397–403.https://dx.doi.org/10.1016/j.jcct.2022.03.006. 13. Al’Aref S.J., Maliakal G., Singh G. et al. Machine learning of clinical variables and coronary artery calcium scoring for the prediction of obstructive coronary artery disease on coronary computed tomography angiography: analysis from the CONFIRM registry. Eur Heart J. 2020; 41(3): 359–67. https://dx.doi.org/10.1093/eurheartj/ehz565.
Grigory E. Roytberg, MD, professor, academician of RAS, head of the Department of therapy, general medical practice and nuclear medicine of the Faculty of additional professional education, N.I. Pirogov Russian National Research Medical University of the Ministry of Healthcare of Russia. Address: 125047, Moscow, 10 2nd Tverskoy-Yamskoy Lane. E-mail: contact@medicina.ru. ORCID: https://orcid.org/0000-0003-0514-9114
Irina D. Slastnikova, PhD in Medicinal Sciences, associate professor of the Department of therapy, general medical practice and nuclear medicine of the Faculty of additional professional education, N.I. Pirogov Russian National Research Medical University of the Ministry of Healthcare of Russia. Address: 125047, Moscow, 10 2nd Tverskoy-Yamskoy Lane. E-mail: slastid@mail.ru. ORCID: https://orcid.org/0000-0002-4076-2849
Olga O. Sharkhun, MD, associate professor, professor of the Department of therapy, general medical practice and nuclear medicine of the Faculty of additional professional education, N.I. Pirogov Russian National Research Medical University of the Ministry of Healthcare of Russia. Address: 125047, Moscow, 10 2nd Tverskoy-Yamskoy Lane. E-mail: olga_sharkhun@mail.ru. ORCID: https://orcid.org/0000-0001-8527-4681
Alina Sh. Davydova, postgraduate student of the Department of therapy, general medical practice and nuclear medicine of the Faculty of additional professional education, N.I. Pirogov Russian National Research Medical University of the Ministry of Healthcare of Russia. Address: 125047, Moscow, 10 2nd Tverskoy-Yamskoy Lane. E-mail: alina.tsyganova@gmail.com. ORCID: https://orcid.org/0000-0002-5738-0740